Prokinetics in the Management of Functional Gastrointestinal Disorders

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Gastroenterology Reports

• Publication date

  2017-09-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11894-017-0593-6PMID 28887755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced Parkinsonism on the rise: Beware of levosulpiride and its combinations with proton pump inhibitors

  2017cited by this paper
• Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists

  2017cited by this paper
• Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone

  2017cited by this paper
• A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia

  2017cited by this paper
• The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia.

  2016cited by this paper
• Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis

  2016cited by this paper
• Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation

  2016cited by this paper
• The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

  2016cited by this paper
• Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers

  2016cited by this paper
• Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial

  2016cited by this paper
• Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort

  2016cited by this paper
• Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease

  2016cited by this paper
• Bowel Disorders.

  2016cited by this paper
• Domperidone-Associated QT Interval Prolongation in Non-oncologic Pediatric Patients: A Review of the Literature.

  2016cited by this paper
• Randomized clinical trial: a controlled pilot trial of the 5‐HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis

  2016cited by this paper
• Levosulpiride-Associated Hemichorea

  2016cited by this paper
• Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.

  2016cited by this paper
• Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a “Black Box” Warning: A Canadian Tertiary Care Center Study

  2016cited by this paper
• Prucalopride exerts neuroprotection in human enteric neurons.

  2016cited by this paper
• Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers

  2015cited by this paper
• A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucalopride

  2015cited by this paper
• Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist

  2015cited by this paper
• Colonic motor abnormalities in slow transit constipation defined by high resolution, fibre‐optic manometry

  2015cited by this paper
• Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.

  2015cited by this paper
• Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

  2015cited by this paper
• The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial

  2015cited by this paper
• Prokinetics in gastroparesis.

  2015cited by this paper
• Response to “Use of Domperidone to Increase Breast Milk Supply: Further Consideration of the Benefit-Risk Ratio Is Required”

  2015cited by this paper
• Effect of 5‐hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation

  2015cited by this paper
• A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.

  2015cited by this paper
• Metoclopramide or domperidone improves post-pyloric placement of spiral nasojejunal tubes in critically ill patients: a prospective, multicenter, open-label, randomized, controlled clinical trial

  2015cited by this paper
• Use of Domperidone to Increase Breast Milk Supply

  2015cited by this paper
• Domperidone prescribing practices exposed patients to cardiac risk despite a 'black box' warning: A Canadian tertiary care centre study.

  2015cited by this paper
• Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders

  2015cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation

  2015cited by this paper
• Novel Prokinetic Acotiamide Reduces Transient Lower Esophageal Sphincter Relaxation in Healthy Subjects

  2015cited by this paper
• Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study

  2015cited by this paper
• Influence of a new 5‐HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation

  2014cited by this paper
• Current Use of Domperidone and Co-prescribing of Medications that Increase Its Arrhythmogenic Potential Among Older Adults: A Population-Based Cohort Study in Ontario, Canada

  2014cited by this paper
• Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects

  2014cited by this paper
• Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.

  2014cited by this paper
• Domperidone for Delayed Gastric Emptying in Lung Transplant Recipients with and without Gastroesophageal Reflux

  2014cited by this paper
• Efficacy and Safety of Acotiamide for the Treatment of Functional Dyspepsia: Systematic Review and Meta-Analysis

  2014cited by this paper
• Absence of QTc Prolongation with Domperidone: A Randomized, Double-Blind, Placebo- and Positive-Controlled Thorough QT/QTc Study in Healthy Volunteers

  2014cited by this paper
• Gastroparesis: separate entity or just a part of dyspepsia?

  2014cited by this paper
• Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

  2014cited by this paper
• Completion rate of small bowel capsule endoscopy is higher after erythromycin compared to domperidone

  2014cited by this paper
• Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor

  2014cited by this paper
• Domperidone-associated sudden cardiac death in the general population and implications for use in patients undergoing hemodialysis: a literature review.

  2014cited by this paper
• Systematic review with meta‐analysis: highly selective 5‐HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation

  2014cited by this paper
• Sudden Cardiac Death and Ventricular Arrhythmias Associated with Domperidone: Evidence Supporting Health Canada's Warning.

  2014cited by this paper
• The mechanism of enhanced defecation caused by the ghrelin receptor agonist, ulimorelin

  2014cited by this paper
• The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis.

  2014cited by this paper
• Prucalopride is no more effective than placebo for children with functional constipation.

  2014cited by this paper
• Effect of acotiamide on gastric emptying in healthy adult humans

  2014cited by this paper
• Domperidone-induced dystonia: a rare and troublesome complication

  2014cited by this paper
• Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.

  2013cited by this paper
• Domperidone: Limited Benefits With Significant Risk for Sudden Cardiac Death

  2013cited by this paper
• Phase 2b, randomized, double‐blind 12‐week studies of TZP‐102, a ghrelin receptor agonist for diabetic gastroparesis

  2013cited by this paper
• A phase 2a, randomized, double‐blind 28‐day study of TZP‐102 a ghrelin receptor agonist for diabetic gastroparesis

  2013cited by this paper
• Diagnostic testing for dyssynergic defecation in chronic constipation: meta‐analysis

  2013cited by this paper
• A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water

  2013cited by this paper
• Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis

  2013cited by this paper
• The Metoclopramide Black Box Warning for Tardive Dyskinesia: Effect on Clinical Practice, Adverse Event Reporting, and Prescription Drug Lawsuits

  2013cited by this paper
• Citalopram and levosulpiride: a dangerous drug combination for QT prolongation.

  2013cited by this paper
• Safety and Efficacy of Ulimorelin Administered Postoperatively to Accelerate Recovery of Gastrointestinal Motility Following Partial Bowel Resection: Results of Two Randomized, Placebo-Controlled Phase 3 Trials

  2013cited by this paper
• The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.

  2013cited by this paper
• Randomized Controlled Phase Ib Study of Ghrelin Agonist, RM-131, in Type 2 Diabetic Women With Delayed Gastric Emptying

  2012cited by this paper
• Prucalopride: safety, efficacy and potential applications

  2012cited by this paper
• Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

  2012cited by this paper
• Rectal hyposensitivity and functional anorectal outlet obstruction are common entities in patients with functional constipation but are not significantly associated

  2012cited by this paper
• Colonoscopy is superior to neostigmine in the treatment of Ogilvie's syndrome.

  2012cited by this paper
• A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation

  2012cited by this paper
• Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study

  2012cited by this paper
• Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study

  2012cited by this paper
• Itopride therapy for functional dyspepsia: a meta-analysis.

  2012cited by this paper
• Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility

  2012cited by this paper
• Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride

  2011cited by this paper
• Cisapride: What can we learn from the rise and fall of a prokinetic?

  2011cited by this paper
• Ghrelin Agonist TZP-101/Ulimorelin Accelerates Gastrointestinal Recovery Independently of Opioid Use and Surgery Type: Covariate Analysis of Phase 2 Data

  2011cited by this paper
• A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

  2011cited by this paper
• Randomised clinical trial: ghrelin agonist TZP‐101 relieves gastroparesis associated with severe nausea and vomiting – randomised clinical study subset data

  2011cited by this paper
• Pancolonic spatiotemporal mapping reveals regional deficiencies in, and disorganization of colonic propagating pressure waves in severe constipation

  2010cited by this paper
• Advantages of Azithromycin Over Erythromycin in Improving the Gastric Emptying Half-Time in Adult Patients With Gastroparesis

  2010cited by this paper
• Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study

  2010cited by this paper
• Constipation, IBs and the 5-HT4 Receptor: What Role for Prucalopride?

  2010cited by this paper
• 905 A Novel Gastrointestinal Prokinetic, ATI-7505, Increased Spontaneous Bowel Movements (Sbms) in a Phase II, Randomized, Placebo-Controlled Study of Patients With Chronic Idiopathic Constipation (CIC)

  2010cited by this paper
• The Ghrelin Agonist TZP-101 for Management of Postoperative Ileus After Partial Colectomy: A Randomized, Dose-Ranging, Placebo-Controlled Clinical Trial

  2010cited by this paper
• Safety and efficacy of ghrelin agonist TZP‐101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo‐controlled study

  2010cited by this paper
• Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.

  2010cited by this paper
• Clinical trial: dose‐dependent therapeutic efficacy of acotiamide hydrochloride (Z‐338) in patients with functional dyspepsia – 100 mg t.i.d. is an optimal dosage

  2010cited by this paper
• Metoclopramide in the treatment of diabetic gastroparesis

  2010cited by this paper
• Domperidone Treatment for Gastroparesis: Demographic and Pharmacogenetic Characterization of Clinical Efficacy and Side-Effects

  2010cited by this paper
• A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsia

  2009cited by this paper
• Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled study

  2009cited by this paper
• Combination therapy of levosulpiride and lamotrigine associated with tardive dyskinesia.

  2009cited by this paper
• Levosulpiride‐induced movement disorders

  2009cited by this paper
• GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.

  2009cited by this paper
• Ghrelin receptor agonist (TZP‐101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis

  2009cited by this paper
• Effects of Velusetrag (TD‐5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

  2009cited by this paper

• Evolving Methodologies for the Analytical Determination of Metoclopramide.

  2026cites this paper
• Overview of prokinetics in the Czech Republic and their current status in the treatment of gastrointestinal motility disorders

  2025cites this paper
• Effects of Two Compound Probiotic Formulations on Gastrointestinal Symptoms and Gut Microbiota: A 4-Week Randomized, Double-Blind Intervention Trial

  2025cites this paper
• Multidisciplinary Assessment and Management of Functional Dysphagia

  2025cites this paper
• Belching, bloating, and flatulence: pitfalls and challenges in evaluating and managing symptoms of intestinal gas and how to avoid them

  2025cites this paper
• Simulated gastrointestinal digestion of walnut protein yields anti-inflammatory peptides.

  2024cites this paper
• Ligustilide improves functional constipation by non-covalently activating TRPA1 in colon tissue.

  2024cites this paper
• Use of prokinetic agents in hospitalised adult patients: A scoping review

  2023cites this paper
• Rhizoma Atractylodis Macrocephalae—Assessing the influence of herbal processing methods and improved effects on functional dyspepsia

  2023cites this paper
• Research trends in the field of the gut-brain interaction: Functional dyspepsia in the spotlight – An integrated bibliometric and science mapping approach

  2023cites this paper
• Role of segmental contraction in the small intestinal digestion: a computational approach to study the physics behind the luminal mixing and transport.

  2023cites this paper
• Efficacy of artichoke and ginger extracts with simethicone to treat gastrointestinal symptoms in endurance athletes: a pilot study

  2022cites this paper
• Use of prokinetic agents in hospitalised adult patients: Protocol for a scoping review

  2022cites this paper
• Potential Mechanisms of Acupuncture for Functional Dyspepsia Based on Pathophysiology

  2022cites this paper
• Characterizing flow due to segmental contraction of the small intestine and their impact on digestion

  2021cites this paper
• Toward a broader view of mechanisms of drug cardiotoxicity

  2021cites this paper
• Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System

  2021cites this paper
• Effects of prokinetics on the digestive tract.

  2021cites this paper
• Managing motility disorders of the gastrointestinal segment and obesity through electrical stimulation

  2021cites this paper
• A pilot study on the efficacy of a rational combination of artichoke and ginger extracts with simethicone in the treatment of gastrointestinal symptoms in endurance athletes.

  2020cites this paper
• A Novel Approach in Spinal Cord Stimulation for Enhancing Gastric Motility: A Preliminary Study on Canines

  2020cites this paper
• Enfermedad por reflujo gastroesofágico

  2020cites this paper
• Chemical composition, antioxidant and gastrointestinal properties of Sedum dendroideum Moc & Sessé ex DC leaves tea infusion.

  2019cites this paper
• Preparation and Evaluation of Mosapride Citrate Dual-Release Dry Suspension

  2019cites this paper
• Advances in understanding relationship between 5-hydroxytryptamine and its receptors and intestinal dysmotility in irritable bowel syndrome

  2019cites this paper
• Non-pharmacological Approach in the Management of Functional Dyspepsia

  2019cites this paper
• Choosing a Prokinetic for Your Patient Beyond Metoclopramide.

  2019cites this paper
• The Investigation and Treatment of Diabetic Gastroparesis.

  2018cites this paper
• A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial

  2018cites this paper
• System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia

  2018cites this paper
• Effects of medicines used to treat gastrointestinal diseases on the pharmacokinetics of coadministered drugs: a PEARRL Review

  2018cites this paper
• Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning?

  2018cites this paper
• Prokinetics in the Management of Functional Gastrointestinal Disorders

  2015cites this paper